The selective dopamine D3 receptor antagonist, SR 21502, reduces cue-induced reinstatement of heroin seeking and heroin conditioned place preference in rats-Reference-Cited by-同舟云学术

The selective dopamine D3 receptor antagonist, SR 21502, reduces cue-induced reinstatement of heroin seeking and heroin conditioned place preference in rats

Published:2015-11 Issue: Volume:156 Page:228-233
ISSN:0376-8716
Container-title:Drug and Alcohol Dependence
language:en
Short-container-title:Drug and Alcohol Dependence

Author:

Galaj Ewa,Manuszak Monica,Babic Sandra,Ananthan Subramaniam,Ranaldi Robert

Publisher

Elsevier BV

Subject

Pharmacology (medical),Psychiatry and Mental health,Pharmacology,Toxicology

Reference86 articles.

1. SCH 23390 blocks drug-conditioned place-preference and place-aversion: anhedonia (lack of reward) or apathy (lack of motivation) after dopamine-receptor blockade?;Acquas;Psychopharmacology (Berl.),1989

2. Acute administration of the selective D3 receptor antagonist SB-277011A blocks the acquisition and expression of the conditioned place preference response to heroin in male rats;Ashby;Synapse,2003

3. The dopamine D(3) receptor-preferring partial agonist BP 897 dose-dependently attenuates the expression of amphetamine-conditioned place preference in rats;Aujla;Behav. Pharmacol.,2005

4. Conditioned place preference with morphine: the effect of extinction training on the reinforcing CR;Bardo;Pharmacol. Biochem. Behav.,1984

5. Single-trial conditioned place preference using intravenous morphine;Bardo;Pharmacol. Biochem. Behav.,1986

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Enhancement of memory consolidation by an avoidance conditioned stimulus: Modulation by the D3 receptor;Neuropharmacology;2023-09

2. The D3 receptor antagonist SR 21502 reduces cue-induced reinstatement of methamphetamine-seeking in rats;Neuroscience Letters;2023-05

3. HIV gp120 impairs nucleus accumbens neuroimmune function and dopamine D3 receptor-mediated inhibition of cocaine seeking in male rats;Addiction Neuroscience;2023-03

4. Opioids;Opioids;2023

5. A highly D3R-selective and efficacious partial agonist (S)-ABS01-113 compared to its D3R-selective antagonist enantiomer (R)-ABS01-113 as potential treatments for opioid use disorder;Neuropsychopharmacology;2022-07-25